Efficacy of parent-infant psychotherapy compared to care as usual in children with regulatory disorders in clinical and outpatient settings: study protocol of a randomised controlled trial as part of the SKKIPPI project

• Published in: BMC psychiatry 2021-02, Vol.21 (1), p.118-118, Article 118
• Main Authors: Sprengeler, Mona Katharina, Mattheß, Janna, Eckert, Melanie, Richter, Katharina, Koch, Gabriele, Reinhold, Thomas, Vienhues, Petra, Berghöfer, Anne, Fricke, Julia, Roll, Stephanie, Keil, Thomas, Ludwig-Körner, Christiane, Kuchinke, Lars, von Klitzing, Kai, Schlensog-Schuster, Franziska
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Attachment; Babies; Care and treatment; Caregivers; Child; Child & adolescent psychiatry; Child psychopathology; Child, Preschool; Children; Children & youth; Clinical assessment; Demographic aspects; Diagnosis; Early childhood; Female; Focus-based psychodynamic intervention; Health aspects; Health care; Humans; Infant; Infant, Newborn; Infants; Intervention; Manualised short-term psychotherapy; Maternal sensitivity; Mental disorders; Mental health; Mother-Child Relations; Mothers; Multicenter Studies as Topic; Outpatients; Parent-Child Relations; Parents & parenting; Patient outcomes; Preschool children; Psychiatry; Psychological aspects; Psychopathology; Psychotherapy; Randomized Controlled Trials as Topic; Study Protocol; Therapists; Young Adult
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/s12888-021-03112-6

The first years of life are a significant period for child development, when children are particularly sensitive and prone to crises. This early phase lays the foundation for healthy growth. Clinical assessment of psychological symptoms in early infancy and adequate treatment are both important in improving the diagnostic outcome and preventing later long-term developmental consequences. The most common psychological problems in the first 3 years of life are regulatory disorders. The aim of this trial is to investigate the efficacy of Parent-Infant Psychotherapy (PIP) for infants and young children (aged 0-36 months, diagnosed with at least one regulatory disorder) and their mothers, compared to care as usual (CAU). In this open multicentre randomised controlled trial, 160 mother-infant dyads are randomised to receive PIP or CAU for 6 weeks of intervention in clinical or outpatient (including home treatment) settings. The primary outcome is the maternal sensitivity (sensitivity scale of the Emotional Availability Scales (EAS)) after 6 weeks. Secondary outcomes include assessment of interaction, mental health problems, attachment, development, psychological factors, treatment adherence, health care system utilisation, and costs, after 6 weeks and 12 months. This study will evaluate whether a manualised focus-based short-term psychodynamic psychotherapeutic intervention in mother-child dyads improves the care situation for families of children diagnosed with regulatory disorders, and helps prevent long-term psychopathologies. Assessment of the intervention in different settings will support the development of more tailored interventions for affected infants and their mothers. German Clinical Trial Register, ID: DRKS00017008 . Registered 03/20/2019.